- Home
- UDMY vs LENZ Comparison
UDMY vs LENZ Comparison
Compare UDMY & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- LENZ
- Stock Information
- Founded
- UDMY 2009
- LENZ 2019
- Country
- UDMY United States
- LENZ United States
- Employees
- UDMY N/A
- LENZ N/A
- Industry
- UDMY Other Consumer Services
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- UDMY Real Estate
- LENZ Health Care
- Exchange
- UDMY Nasdaq
- LENZ Nasdaq
- Market Cap
- UDMY 904.2M
- LENZ 819.1M
- IPO Year
- UDMY 2021
- LENZ 2021
- Fundamental
- Price
- UDMY $7.32
- LENZ $29.35
- Analyst Decision
- UDMY Buy
- LENZ Strong Buy
- Analyst Count
- UDMY 11
- LENZ 5
- Target Price
- UDMY $9.90
- LENZ $41.80
- AVG Volume (30 Days)
- UDMY 866.7K
- LENZ 180.2K
- Earning Date
- UDMY 07-30-2025
- LENZ 05-07-2025
- Dividend Yield
- UDMY N/A
- LENZ N/A
- EPS Growth
- UDMY N/A
- LENZ N/A
- EPS
- UDMY N/A
- LENZ N/A
- Revenue
- UDMY $790,019,000.00
- LENZ N/A
- Revenue This Year
- UDMY $1.87
- LENZ N/A
- Revenue Next Year
- UDMY $4.15
- LENZ $534.98
- P/E Ratio
- UDMY N/A
- LENZ N/A
- Revenue Growth
- UDMY 5.43
- LENZ N/A
- 52 Week Low
- UDMY $5.68
- LENZ $14.42
- 52 Week High
- UDMY $10.61
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- UDMY 58.35
- LENZ 57.47
- Support Level
- UDMY $6.70
- LENZ $28.14
- Resistance Level
- UDMY $7.50
- LENZ $30.09
- Average True Range (ATR)
- UDMY 0.25
- LENZ 1.51
- MACD
- UDMY 0.07
- LENZ 0.02
- Stochastic Oscillator
- UDMY 77.50
- LENZ 78.14
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.